Abstract:Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.

A Potential Model for Studying the Plasticity and Reprogramming of Human Epidermal Stem Cells Through Preimplantation Blastocyst Microinjection.

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Controlled Modelling of Human Epiblast and Amnion Development Using Stem Cells.

In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells

A microfluidics-based stem cell model of early post-implantation human development

Derivation of Mouse Parthenogenetic Advanced Stem Cells

A Rapid and Stable Spontaneous Reprogramming System of Spermatogonial Stem Cells to Pluripotent State.

High-throughput Screening in Postimplantation Haploid Epiblast Stem Cells Reveals Hs3st3b1 As a Modulator for Reprogramming

Generation of Human Epidermis-Derived Mesenchymal Stem Cell-like Pluripotent Cells and their reprogramming in mouse chimeras

Reprogramming of human adipose mesenchymal stem cells to induced pluripotent stem cells using a polycistronic plasmid

Pluripotent stem cells secrete Activin A to improve their epiblast competency after injection into recipient embryos

Converting Mouse Epiblast Stem Cells into Mouse Embryonic Stem Cells by Using Small Molecules.

Human Embryos in a Dish – Modeling Early Embryonic Development with Pluripotent Stem Cells

Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells

Derivation of hypermethylated pluripotent embryonic stem cells with high potency

Advances in Mouse Epiblast Stem Cell

A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells.

Generation of Blastocyst-like Structures from Mouse Embryonic and Adult Cell Cultures.

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Timely stimulation of early embryo promotes the acquisition of pluripotency